CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses

Yu Chen(Shanghai University), Genhong Cheng(University of California, Los Angeles)
Cancer Immunology Research
February 18, 2022
Cited by 35


Related Papers